Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor - Optimize Trial (OPTIMIZE)

This study has been completed.
Sponsor:
Collaborator:
Medtronic
Information provided by (Responsible Party):
Cardiovascular Research Center, Brazil
ClinicalTrials.gov Identifier:
NCT01113372
First received: April 22, 2010
Last updated: December 17, 2015
Last verified: December 2015